Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by RodneyCameronon Feb 22, 2017 1:32pm
399 Views
Post# 25878249

RE:RE:RE:RE:Oh This Stock

RE:RE:RE:RE:Oh This Stock

Sir, I am not disputing that they paid with cash because good heavens they can't get any more debt.  I am fisputing your prior comment that they still have cash on hand.  You have no idea how much cash they have, in the prior releases they always stated what their cash position was AFTER the payment.  This one they did not.  


I don't want to argue with you.  You are obviously upset with the last five days decline in this stock and you seem to have a mission to slam all the bearish posts on this board.  

The bottom line is that the current bond yield of 30% on Concordia bonds says that this comopany is distressed and even the unsecured bondholders don't think they will get their money back - which doesn't bode well for common stock holders.

Chill man....     This is just a bullboard. 

MrHulot wrote:

It doesn’t seem you undertand the “point” of anything nor able to read a Press release.

T.CXR 

 

PR Newswire

OAKVILLE, ONFeb. 1, 2017 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, today announced that it has paid the second and final installment of its earn-out to Cinven1 relating to Concordia's October 2015 acquisition of Amdipharm Mercury Limited.

Today's payment of £72 million, plus interest of approximately £1.5 million, was paid with cash on hand.


Read more at https://www.stockhouse.com/news/press-releases/2017/02/01/concordia-international-corp-makes-final-earn-out-payment-to-cinven#1KBkbuuDrxdaxT2K.99



<< Previous
Bullboard Posts
Next >>